Sobetirome Explained
Routes Of Administration: | Oral |
Legal Status: | Investigational |
Synonyms: | GC-1 |
Cas Number: | 211110-63-3 |
Chebi: | 79988 |
Chembl: | 107400 |
Chemspiderid: | 8037944 |
Iuphar Ligand: | 2639 |
Kegg: | D09381 |
Pubchem: | 9862248 |
Unii: | XQ31741E9Q |
Drugbank: | DB07425 |
Stdinchi: | 1S/C20H24O4/c1-12(2)17-9-15(5-6-19(17)21)10-18-13(3)7-16(8-14(18)4)24-11-20(22)23/h5-9,12,21H,10-11H2,1-4H3,(H,22,23) |
Stdinchikey: | QNAZTOHXCZPOSA-UHFFFAOYSA-N |
Smiles: | CC1=CC(=CC(=C1CC2=CC(=C(C=C2)O)C(C)C)C)OCC(=O)O |
Iupac Name: | 2-[4-[(4-Hydroxy-3-propan-2-ylphenyl)methyl]-3,5-dimethylphenoxy]acetic acid |
C: | 20 |
H: | 24 |
O: | 4 |
Sobetirome (GC-1) is a thyromimetic drug that binds to the thyroid hormone receptor TRβ1 preferentially compared to TRα1. It has been investigated for the treatment of dyslipidemia, obesity,[1] Pitt–Hopkins syndrome,[2] cholestatic liver disease,[3] multiple sclerosis,[4] bleomycin-induced lung fibrosis,[5] and COVID-19 caused ARDS.[6] It was designated as an orphan drug by the FDA for the treatment of X-linked adrenoleukodystrophy.[7]
Notes and References
- Lammel Lindemann . Jan . Webb . Paul . Sobetirome: the past, present and questions about the future . Expert Opinion on Therapeutic Targets . 2016 . 20 . 2 . 145–149 . 10.1517/14728222.2016.1090429 . 26565124 . 1744-7631. free .
- Bohlen . Joseph F . Cleary . Colin M . Das . Debamitra . Sripathy . Srinidhi Rao . Sadowski . Norah . Shim . Gina . Kenney . Rakaia F . Buchler . Ingrid P . Banerji . Tapasree . Scanlan . Thomas S . Mulkey . Daniel K . Maher . Brady J . Promyelinating drugs promote functional recovery in an autism spectrum disorder mouse model of Pitt–Hopkins syndrome . Brain . 1 August 2023 . 146 . 8 . 3331–3346 . 10.1093/brain/awad057 . free . 37068912 . 10393406 .
- Kosar . Karis . Cornuet . Pamela . Singh . Sucha . Liu . Silvia . Nejak-Bowen . Kari . The Thyromimetic Sobetirome (GC-1) Alters Bile Acid Metabolism in a Mouse Model of Hepatic Cholestasis . The American Journal of Pathology . May 2020 . 190 . 5 . 1006–1017 . 10.1016/j.ajpath.2020.01.015 . 32205094 . 7221298 . 0002-9440.
- Book: Shah . Kamal . Chauhan . Durgesh Nandini . Chauhan . Nagendra Singh . Mishra . Pradeep . Recent Advancement in Prodrugs . 13 May 2020 . CRC Press . 978-1-000-05799-7 . en.
- Matralis . Alexios . Karampitsakos . Theodoros . Papaioannou . Ourania . Katsaras . Matthaios . Sampsonas . Fotios . Bouros . Demosthenes . Aidinis . Vassilis . Tzouvelekis . Argyrios . Biosynthesis and implementation of Thyroid Receptor beta (TRß) agonists (thyromimetics) for the treatment of pulmonary fibrosis . European Respiratory Journal . 5 September 2021 . 58 . suppl 65 . OA4334 . 10.1183/13993003.congress-2021.OA4334 . 244680799 . en . 0903-1936.
- Web site: Hartley . Pamela . $100,000 Gift Speeds Exploration of Sobetirome as COVID-19 Treatment . medicine.yale.edu . 15 September 2023 . en.
- Web site: Search Orphan Drug Designations and Approvals . www.accessdata.fda.gov . 15 September 2023.